Viral Oncology Program, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, 1650 Orleans Street, CRB1 3M09, Baltimore, MD 21231, USA.
Immunity. 2010 Dec 14;33(6):863-77. doi: 10.1016/j.immuni.2010.11.027.
In the course of combating infectious agents, type I interferon (IFN) needs a timely downregulation mechanism to avoid detrimental overreaction. Here we showed a mechanism for restraining type I IFN responses, which relied on a HECT domain ubiquitin (Ub) E3 ligase, RAUL. RAUL limited type I IFN production by directly catalyzing lysine 48-linked polyubiquitination of both interferon regulatory factor 7 (IRF7) and IRF3 followed by proteasome-dependent degradation. Suppression of RAUL by dominant-negative RAUL or siRNA augmented both basal and virus-induced production of type I IFN, which resulted in reduced viral replication. The Kaposi's sarcoma-associated herpes virus immediate-early lytic cycle trigger protein RTA recruited this mechanism to augment its countermeasures against the host antiviral response. These results unveil a previously unrecognized "brake mechanism" for type I IFN that maintains proper low amounts of type I IFN under physiological conditions and restrains its magnitude when the antiviral response intensifies.
在与传染性病原体的斗争中,I 型干扰素(IFN)需要一种及时的下调机制来避免有害的过度反应。在这里,我们展示了一种限制 I 型 IFN 反应的机制,该机制依赖于一种 HECT 结构域泛素(Ub)E3 连接酶 RAUL。RAUL 通过直接催化干扰素调节因子 7(IRF7)和 IRF3 的赖氨酸 48 位连接的多泛素化,随后通过蛋白酶体依赖性降解,限制 I 型 IFN 的产生。显性负性 RAUL 或 siRNA 抑制 RAUL 会增强 I 型 IFN 的基础和病毒诱导产生,从而导致病毒复制减少。卡波西肉瘤相关疱疹病毒立即早期裂解周期触发蛋白 RTA 募集了这种机制来增强其对抗宿主抗病毒反应的对策。这些结果揭示了一种以前未被识别的 I 型 IFN“制动机制”,该机制在生理条件下维持适当的低水平 I 型 IFN,并在抗病毒反应增强时限制其幅度。